Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_2
1
17%
Ph not_applicable
2
33%
Ph phase_3
3
50%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
3(50.0%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (16.7%)
Phase 33 (50.0%)
N/A2 (33.3%)

Trials by Status

completed467%
terminated117%
unknown117%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

NCT00026286
completednot_applicable

Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure

NCT01023178
terminatedphase_3

Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer

NCT00002976
completedphase_2

AFTER: Altering Fat Through Estrogen and Raloxifene

NCT00149604
unknownnot_applicable

Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer

NCT00079248
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00026286Phase 3

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

Completed
NCT01023178Not Applicable

Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure

Completed
NCT00002976Phase 3

Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer

Terminated
NCT00149604Phase 2

AFTER: Altering Fat Through Estrogen and Raloxifene

Completed
NCT00079248Not Applicable

Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer

Unknown
NCT00004650Phase 3

Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6